Literature DB >> 2165766

HSV-1 gB and VZV gp-II crossreactive antibodies in human sera.

J E Kühn1, K Klaffke, K Munk, R W Braun.   

Abstract

The specificity and prevalence of human IgG antibodies crossreactive between HSV-1 (ANG) and VZV (Ellen) was examined in immunoblots. Using antibody fractions purified on HSV- and VZV-coated affinity chromatography columns and by preadsorption of sera with HSV and/or VZV lysates a crossreactivity between HSV-1 gB and VZV gp-II was demonstrated. Crossreaction of human IgG antibodies among other structural and nonstructural viral proteins, however, was not detected. The frequency of human IgG antibodies crossreactive between HSV-1 gB and VZV gp-II was highest in HSV-seropositive patients experiencing an acute primary VZV infection (4 out of 5 sera tested). In contrast, no crossreactive antibodies were found in sera of HSV-seronegative patients with acute primary VZV infection (0/6) or in sera from individuals with acute recurrent HSV or VZV infection (0/12). Analysis of sera from individuals with previous HSV and/or VZV infection showed the presence of antibodies crossreactive between HSV-1 gB and VZV gp-II in 3 out of 30 sera tested.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2165766     DOI: 10.1007/BF01323165

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  28 in total

1.  An octamer of histones in chromatin and free in solution.

Authors:  J O Thomas; R D Kornberg
Journal:  Proc Natl Acad Sci U S A       Date:  1975-07       Impact factor: 11.205

Review 2.  The avidin-biotin complex in bioanalytical applications.

Authors:  M Wilchek; E A Bayer
Journal:  Anal Biochem       Date:  1988-05-15       Impact factor: 3.365

3.  Immunological conservation between Epstein-Barr virus and herpes simplex virus.

Authors:  E Littler; I W Halliburton; K L Powell; B W Snowden; J R Arrand
Journal:  J Gen Virol       Date:  1988-08       Impact factor: 3.891

4.  Properties of plaque variants of herpes virus hominis strains of genital origin.

Authors:  K Munk; G Ludwig
Journal:  Arch Gesamte Virusforsch       Date:  1972

5.  Immunological relationship between herpes simplex and varicella-zoster viruses demonstrated by complement-fixation, neutralization and fluorescent antibody tests.

Authors:  N J Schmidt; E H Lennette; R L Magoffin
Journal:  J Gen Virol       Date:  1969-04       Impact factor: 3.891

6.  The immune response to herpes simplex virus: comparison of the specificity and relative titers of serum antibodies directed against viral polypeptides following primary herpes simplex virus type 1 infections.

Authors:  R Eberle; S W Mou; J A Zaia
Journal:  J Med Virol       Date:  1985-06       Impact factor: 2.327

7.  Nucleotide sequence specifying the glycoprotein gene, gB, of herpes simplex virus type 1.

Authors:  D J Bzik; B A Fox; N A DeLuca; S Person
Journal:  Virology       Date:  1984-03       Impact factor: 3.616

8.  Antigenic cross-reactions among herpes simplex virus types 1 and 2, Epstein-Barr virus, and cytomegalovirus.

Authors:  N Balachandran; D E Oba; L M Hutt-Fletcher
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

9.  Removal of N-linked carbohydrates decreases the infectivity of herpes simplex virus type 1.

Authors:  J E Kühn; B R Eing; R Brossmer; K Munk; R W Braun
Journal:  J Gen Virol       Date:  1988-11       Impact factor: 3.891

10.  Identification of cross-reacting glycoproteins of four herpesviruses by Western blotting.

Authors:  B W Snowden; I W Halliburton
Journal:  J Gen Virol       Date:  1985-09       Impact factor: 3.891

View more
  6 in total

1.  Evaluation of confirmatory strategies for detection of type-specific antibodies against herpes simplex virus type 2.

Authors:  Bodo Rolf Eing; Lars Lippelt; Eva Ulla Lorentzen; Wali Hafezi; Wolfgang Schlumberger; Katja Steinhagen; Joachim Ewald Kühn
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

2.  Varicella-zoster virus (VZV) glycoprotein E is a serological antigen for detection of intrathecal antibodies to VZV in central nervous system infections, without cross-reaction to herpes simplex virus 1.

Authors:  Anna Grahn; Marie Studahl; Staffan Nilsson; Elisabeth Thomsson; Malin Bäckström; Tomas Bergström
Journal:  Clin Vaccine Immunol       Date:  2011-06-22

3.  Production of herpes B virus recombinant glycoproteins and evaluation of their diagnostic potential.

Authors:  Ludmila Perelygina; Irina Patrusheva; Soumya Hombaiah; Holley Zurkuhlen; Martin J Wildes; Nikolai Patrushev; Julia Hilliard
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

4.  Reactivity of varicella-zoster virus subunit antigens in enzyme-linked immunosorbent assay to sera from varicella, zoster, and herpes simplex virus infections.

Authors:  M Takayama
Journal:  Med Microbiol Immunol       Date:  1994-02       Impact factor: 3.402

5.  Use of baculovirus-expressed glycoprotein H in an enzyme-linked immunosorbent assay developed to assess exposure to chelonid fibropapillomatosis-associated herpesvirus and its relationship to the prevalence of fibropapillomatosis in sea turtles.

Authors:  Lawrence H Herbst; Shefali Lemaire; Ada R Ene; David J Heslin; Llewellyn M Ehrhart; Dean A Bagley; Paul A Klein; Jack Lenz
Journal:  Clin Vaccine Immunol       Date:  2008-03-26

6.  A DNA Vaccine Formulated with Chemical Adjuvant Provides Partial Protection against Bovine Herpes Virus Infection in Cattle.

Authors:  Valeria Quattrocchi; Ivana Soria; Cecilia Ana Langellotti; Victoria Gnazzo; Mariela Gammella; Dadin P Moore; Patricia I Zamorano
Journal:  Front Immunol       Date:  2017-01-25       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.